Advisory Board and Editors Molecular Biology
Simon F Shamoun
Experienced Research Scientist with a demonstrated history of working with the Canadian Forest Service. Skilled in Forest Pathology, Forest Indigenous & Invasive Alien Pathogens, Sequence Analysis, Real-Time Polymerase Chain Reaction (qPCR), Epidemiology, and Molecular Ecology. Strong research professional with a M.Sc. & Doctor of Philosophy (Ph.D.) degrees focused in Forest Pathology, Biotechnology & Forest Pest Management from N.C. State University & University of Arkansas, USA, respectively.
Huashan Shi
Professor Shi Huashan is an Associate Professor at Sichuan University. His expertise is in the molecular biology of tumours and tumour transcriptomics. He is currently engaged in clinical and basic translational research, including tumour microenvironment and novel immunotherapeutic modalities, and research on the mechanisms and medical applications related to tumour cell vaccines.
Arif J Siddiqui
Dr. Arif Jamal Siddiqui is an Associate Professor and Principal Investigator at the Department of Biology, College of Science, University of Hail, Saudi Arabia. He received his PhD from CSIR-Central Drug Research Institute, Lucknow, India in 2015. From 2015 to 2018, he worked as a Post-Doctoral Fellow at Texas Tech University Health Sciences Center, Lubbock, Texas, United States of America.
He has more than 8 years of experience in research, teaching and administration. In his professional work, he has received research grants as a Principal Investigator from various renowned organizations. He has successfully published more than 100 publications in internationally recognized peer-reviewed prestigious journals, published several book chapters for internationally renowned publishers and presented many articles and posters in various conferences/workshops worldwide. He has published numerous papers in the fields of parasitology, immunology, herbal medicine, vaccine development, drug discovery and natural products with a specialization in anti-parasitic, antiviral, anticancer and antibacterial agents. Furthermore, he is a member of The Indian Science Congress Association, India and the Annals of Parasitology, Poland. He has reviewed more than 250 manuscripts and he also currently holds various editorial positions (Academic, Associate, Guest and Review Editor) in various reputable journals and has edited more than 150 manuscripts.
Jerson L. Silva
Professor of Biochemistry in the Institute of Medical Biochemistry at Universidade Federal do Rio de Janeiro. Awards include Fellow of the John Simon Guggenheim Foundation, TWAS Prize in Biology. Member of the Brazilian Academy of Sciences; the National Academy of Medicine; and Fellow of the Academy of Sciences for the Developing World (TWAS). Director of the Jiri Jonas National Center for Nuclear Magnetic Resonance (UFRJ)
Alison J Sinclair
BSc in Biochemistry from UCL London UK; PhD Cancer Virology at the Imperial Cancer Research Fund, London UK; post-doctoral fellowship at the European Molecular Biology Laboratory in Heidelberg, Germany, researching transcription; post-doctoral fellowship and assistant member of staff at the Ludwig Institute for Cancer Research in London, investigating a transcription factor network in Epstein-Barr virus and cell cycle regulation. Faculty School of Life Sciences at the University of Sussex, UK.
Amit Singh
Dr. Singh received his B.Sc. from the Government Degree College Nahan, H.P. University, India and his M.Sc. and Ph.D from Devi Ahilya University, Indore, India. After a short stint as a Research Associate in the field of Trangenics of silkworm, Bombyx mori, in Indian Institute of Sciences (IISc.), Bangalore, India, Dr. Singh moved to Academic Sinica Taiwan to pursue post doctoral research in the field of eye development using Drosophila melanogaster model system. In 2002, Dr. Singh moved to Baylor College of Medicine, Houston, Texas to further pursue his work on Drosophila eye development and was promoted to an instructor (non-tenure track faculty) position in 2004. Dr. Singh was hired at University of Dayton as a tenure track assistant professor in 2007 and promoted to associate professor in 2013. To date, he has published one book and 52 papers.
Rajesh Kumar Singh
Dr. Rajesh Kumar Singh received his BPharm (2003) and MPharm (2005) from UIPS, Panjab University, Chandigarh. He started to teach pharmaceutical chemistry at the Shivalik College of Pharmacy, Nangal, in 2006, where he completed his PhD in 2013 from IKG Punjab Technical University (IKGPTU), Jalandhar. His major areas of research interest are computer-aided drug-design, polymer-drug conjugates for targeted delivery to CNS and cancerous cells, antimalarial therapeutic agents, and green chemistry approaches for chemical synthesis. Dr. Singh has over 15 years of teaching experience and has guided one 03 Ph.D. and 20 PG students. He is currently guiding 02 PhDs and 02 MPharm students. He has published more than 70 peer-reviewed SCI/SCOPUS-indexed scientific papers with a total JCR Impact Factor of more than 200 in various chemistry and pharmacy journals such as European Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica-B, Bioorganic Chemistry, Biomedicine and Pharmacotherapy, Pharmaceutical Research, European Journal of Pharmaceutical Sciences, Mini-Reviews in Medicinal Chemistry, Pharmaceutical Research, Med. Chem. Res., J. Enzyme Inhi. Med Chem., Res. Chem. Intermediate etc as main or corresponding author. He currently serves as an Editorial Advisory Board Member of 10 international journals, including the SCI-indexed MRMC (Bentham) and PeerJ. He has received the Publon Award 2016, 2017 and the Publon "Excellent Peer Reviewer Award" for outstanding reviewing of more than 290 research papers in different international journals of ACS, RSC, Springer, Elsevier, Dove, Informa, and Bentham whose Impact Factor varies from 1.0 to 12.5. He also has over 60 National and International Conference Abstracts, 5 Books, 5 Best Paper Presentation Awards, 1 Travel Grant to attend International Conferences, and 5 Research Projects funded by Indian Government Agencies. He is also on the panel of international reviewers for research proposals for Royal Society Grants. He is also serving as a PUBLON ACADEMY MENTOR and a BENTHAM BRAND AMBASSADOR. He has been recognized by the Editors as an OUTSTANDING REVIEWER for RSC Medicinal Chemistry journal (IF 4.1, Q1) and also for BENTHAM PUBLISHER in 2023. His name is recently featured in the list of top 2% scientists (2023) ranked by team of Stanford University, USA and Elsevier.
Nikolajs Sjakste
Experience
1978 -1987; Researcher in the Cancer Cell Chemistry Laboratory, Institute of Experimental and Clinical Medicine, Riga, Latvia.
Professor of Medical Biochemistry and Medical Genetics, University of Latvia, Faculty of Medicine (since 1998). Address: Jelgavas Street 1, Riga LV1004 Latvia. Chief of the Department of Medical Biochemistry (2011).
Leading researcher (since 2011) and Head of the Biochemistry Group, Department of Medicinal Chemistry, Latvian Institute of Organic Synthesis (since 1990).
1995 and 1997 “Red position” of CNRS 1993-1998; Institut Jacques Monod, Université Paris VII, Laboratoire de Biochimie de Différentiation, Paris, France.
Education:
Degree of Doctor of Biological Sciences (Dr. habil.), 1992, Institute of Experimental Medicine, St.-Petersburg, Russia. Degree of Candidate of Biological Sciences (Ph. D.), 1984, Cancer Research Centre, Moscow, Russia. Diploma with Distinction in Medical Biophysics, graduated from the Medico-Biological faculty of the 2nd Moscow Medical Institute, Moscow, Russia, 1978.
Paula Soares
Professor of Biopathology at Medical Faculty of the University of Porto and coordinator of Cancer Signaling and Metabolism research group at IPATIMUP/I3S.
Mitchell S Stark
For the past 20 years I have been actively working in the field of melanoma and naevi genomics. I have worked and performed my PhD candidature based at the QIMR Berghofer Medical Research Institute (1999-2015) and in 2015 I relocated as a Research Fellow in the Dermatology Research Centre, The University of Queensland Diamantina Institute. Over this time I have been working towards understanding the aetiology of melanoma, studying gene dysregulation during tumour progression along with predisposition to melanoma in families with high risk for melanoma development. My research group (genomics and miRNA biomarker discovery) based within the Dermatology Research Centre (UQDI) is currently engaged in miRNA biomarker and genomics research for early detection in melanoma, skin cancer (SCC), as well as non-small cell lung cancer.
Dirk Steinke
Dr. Dirk Steinke is an Adjunct Professor within the Department of Integrative Biology at the University of Guelph.
His research program focuses on various themes at the intersection of evolution, ecology and genomic science.
- Mitonuclear coevolution
- Coevolution of Complex IV in fishes
- Improved understanding of niche differentiation
Ursula Stochaj
Associate Professor in the Department of Physiology at McGill University, Montreal.
Research interests: protein and RNA transport, nuclear function and organization, stress, signaling, chaperones, nanobiology, stem cell biology, microscopy, quantitative image analysis, high-throughput screening.